TriMas Corporation (NASDAQ:TRS – Get Free Report) Director Herbert Parker sold 15,000 shares of the firm’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $45.03, for a total value of $675,450.00. Following the completion of the sale, the director directly owned 57,762 shares of the company’s stock, valued at approximately $2,601,022.86. This trade represents a 20.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
TriMas Price Performance
NASDAQ:TRS opened at $42.01 on Friday. The business’s fifty day moving average price is $40.79 and its 200 day moving average price is $37.69. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 1.75 and a beta of 0.59. The company has a current ratio of 4.85, a quick ratio of 4.50 and a debt-to-equity ratio of 0.27. TriMas Corporation has a 1-year low of $28.98 and a 1-year high of $45.42.
TriMas (NASDAQ:TRS – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The industrial products company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.24). TriMas had a return on equity of 8.38% and a net margin of 93.79%.The business had revenue of $168.28 million for the quarter, compared to analyst estimates of $158.24 million. During the same quarter in the previous year, the business posted $0.46 earnings per share. The company’s revenue was up 10.3% compared to the same quarter last year. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS. On average, sell-side analysts forecast that TriMas Corporation will post 1.67 earnings per share for the current fiscal year.
TriMas Announces Dividend
Analyst Ratings Changes
TRS has been the topic of a number of research analyst reports. Zacks Research upgraded shares of TriMas from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 5th. Weiss Ratings raised shares of TriMas from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, TriMas presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.50.
Get Our Latest Stock Analysis on TriMas
Institutional Investors Weigh In On TriMas
A number of hedge funds and other institutional investors have recently made changes to their positions in TRS. AdvisorNet Financial Inc acquired a new stake in shares of TriMas during the 1st quarter valued at about $28,000. Covestor Ltd increased its holdings in TriMas by 20,525.0% in the fourth quarter. Covestor Ltd now owns 825 shares of the industrial products company’s stock worth $29,000 after buying an additional 821 shares during the last quarter. Los Angeles Capital Management LLC acquired a new position in TriMas in the fourth quarter worth approximately $29,000. Ball & Co Wealth Management Inc. bought a new position in TriMas during the fourth quarter valued at approximately $35,000. Finally, Rockefeller Capital Management L.P. raised its position in TriMas by 1,958.0% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,029 shares of the industrial products company’s stock valued at $36,000 after acquiring an additional 979 shares in the last quarter. 99.42% of the stock is owned by hedge funds and other institutional investors.
TriMas Company Profile
TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.
The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.
Further Reading
- Five stocks we like better than TriMas
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.
